(Q33638852)

28 July 2017

1 reference

title

The scientific, quasi-scientific and popular literature on the use of St. John's Wort in the treatment of depression (English)

1 reference

28 July 2017

Deltito J

1

1 reference

28 July 2017

Beyer D

series ordinal

2

1 reference

28 July 2017

publication date

1 December 1998

1 reference

Journal of Affective Disorders

28 July 2017

published in

1 reference

28 July 2017

volume

51

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

345-351

1 reference

In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

St John's wort as an antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

St. John's Wort, an anti-depressant? A systematic, criteria-based review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

A New Italian Pedigree with Early-Onset Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Hypericum treatment of mild depressions with somatic symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Treatment of Seasonal Affective Disorder (SAD) with Hypericum Extract

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Effects of hypericum extract on the expression of serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Biologically active and other chemical constituents of the herb of Hypericum perforatum L.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Testing the antidepressant effects of Hypericum species on animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Inhibition of MAO and COMT by hypericum extracts and hypericin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Controlled clinical trials of hypericum extracts in depressed patients--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Pharmaceutical quality of hypericum extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900008-7

7 January 2021

Pharmaceutical Quality of Hypericum Extracts

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1177/089198879400701S18

Identifiers

DOI

10.1016/S0165-0327(99)00008-7

1 reference

28 July 2017

1 reference